The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Open accessAbstract
BACKGROUND: There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers. METHODS: A total of 13,195 men (primary analysis) and 2594 women (subgroup analyses) between the ages of 50 and 74 were randomly assigned to undergo CT screening at T0 (baseline), year 1, year 3, and year 5.5 or no screening. We obtained data on cancer diagnosis and the date and cause of death through linkages with national registries in the Netherlands and Belgium, and a review committee confirmed lung cancer as the cause of death when possible. A minimum follow-up of 10 years until December 31, 2015, was completed for all participants. RESULTS: Among men, the average adherence to CT screening was 90.0%. On average, 9.2% of the screened participants underwent at least one additional CT scan (initially indeterminate). The overall referral rate for suspicious nodules was 2.1%. At 10 years of follow-up, the incidence of lung cancer was 5.58 cases per 1000 person-years in the screening group and 4.91 cases per 1000 person-years in the control group; lung-cancer mortality was 2.50 deaths per 1000 person-years and 3.30 deaths per 1000 person-years, respectively. The cumulative rate ratio for death from lung cancer at 10 years was 0.76 (95% confidence interval [CI], 0.61 to 0.94; P = 0.01) in the screening group as compared with the control group, similar to the values at years 8 and 9. Among women, the rate ratio was 0.67 (95% CI, 0.38 to 1.14) at 10 years of follow-up, with values of 0.41 to 0.52 in years 7 through 9. CONCLUSIONS: In this trial involving high-risk persons, lung-cancer mortality was significantly lower among those who underwent volume CT screening than among those who underwent no screening. There were low rates of follow-up procedures for results suggestive of lung cancer. (Funded by the Netherlands Organization of Health Research and Development and others; NELSON Netherlands Trial Register number, NL580.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“demonstrating that low-dose computed tomography substantially reduces deaths from lung cancer.”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J. H., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,504
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,078
Mass screening for lung cancer with mobile spiral computed tomography scanner
Sone, S., Takashima, S., Li, F., Yang, Z., Honda, T., Maruyama, Y., Hasegawa, M., Yamanda, T., Kubo, K., Hanamura, K., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08229-9 · Cited by 931
Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.
Kaneko, M., Eguchi, K., Ohmatsu, H., Kakinuma, R., Naruke, T., Suemasu, K., & Moriyama, N. (1996) · Radiology · doi:10.1148/radiology.201.3.8939234 · Cited by 832
Management of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R. M., van Iersel, C. A., van den Bergh, K. A. M., Westeinde, S. C. V. ‘., van der Aalst, C. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 817
Self-citationOverdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Cited by
Sorted by citations
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21871 · Cited by 3,609
Thai, A. A., Solomon, B., Sequist, L. V. D., Gainor, J. F., & Heist, R. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00312-3 · Cited by 2,753
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Rudin, C. M., Brambilla, E. M., Finn, C. F., & Sage, J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00235-0 · Cited by 1,675
The global burden of lung cancer: current status and future trends
Leiter, A., Veluswamy, R. R., & Wisnivesky, J. P. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00798-3 · Cited by 1,610
Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A. G. N., Celli, B. R., Criner, G. J., Halpin, D. M. G., Anzueto, A., Barnes, P. J., Bourbeau, J., Han, M. K., Martínez, F. J., de, M. M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00239-2023 · Cited by 1,467
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A. G. N., Celli, B. R., Criner, G. J., Halpin, D. M. G., Anzueto, A., Barnes, P. J., Bourbeau, J., Han, M. K., Martínez, F. J., de, M. M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0106pp · Cited by 920
Menon, U., Gentry-Maharaj, A., Burnell, M., Singh, N., Ryan, A., Karpinskyj, C., Carlino, G., Taylor, J., Massingham, S. K., Raikou, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00731-5 · Cited by 730
Integrating genomic features for non-invasive early lung cancer detection
Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., Schroers‐Martin, J. G., Nabet, B. Y., Chen, B., Chaudhuri, A. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2140-0 · Cited by 692
Update 2020: Management of Non-Small Cell Lung Cancer
Alexander, M., Kim, S. Y., & Cheng, H. (2020) · Lung · doi:10.1007/s00408-020-00407-5 · Cited by 663
Screening for Lung Cancer With Low-Dose Computed Tomography
Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M. T., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., et al. (2021) · JAMA · doi:10.1001/jama.2021.0377 · Cited by 674
Hendriks, L. E. L., Remón, J., Finn, C. F., Garassino, M. C., Heymach, J. V., Kerr, K. M., Tan, D. S. W., Veronesi, G., & Reck, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00551-9 · Cited by 690
Kratzer, T. B., Bandi, P., Freedman, N. D., Smith, R. A., Travis, W. D., Jemal, A., & Siegel, R. L. (2024) · Cancer · doi:10.1002/cncr.35128 · Cited by 570
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E., & Field, J. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00432-6 · Cited by 521
Self-citationEvaluating the Patient With a Pulmonary Nodule
Mazzone, P. J., & Lam, L. (2022) · JAMA · doi:10.1001/jama.2021.24287 · Cited by 509
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Mathios, D., Johansen, J. S., Cristiano, S., Medina, J. E., Phallen, J. A., Larsen, K. R., Bruhm, D. C., Niknafs, N., Ferreira, L., Adleff, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24994-w · Cited by 476
The future of early cancer detection
Fitzgerald, R. C., Antoniou, A. C., Fruk, L., & Rosenfeld, N. (2022) · Nature Medicine · doi:10.1038/s41591-022-01746-x · Cited by 486
Global burden and trends of lung cancer incidence and mortality
Li, C., Lei, S., Ding, L., Xu, Y., Wu, X., Wang, H., Zhang, Z., Gao, T., Zhang, Y., & Li, L. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002529 · Cited by 539
Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H., & Jemal, A. (2026) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70043 · Cited by 452
Adams, S. J., Stone, E., Baldwin, D. R., Vliegenthart, R., Lee, P., & Fintelmann, F. J. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01694-4 · Cited by 467
Self-citationZhou, J., Xu, Y. H., Liu, J., Feng, L., Yu, J., & Chen, D. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102693 · Cited by 444
Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies
Succony, L., Rassl, D., Barker, A., McCaughan, F., & Rintoul, R. C. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102237 · Cited by 356
The Role of Artificial Intelligence in Early Cancer Diagnosis
Hunter, B., Hindocha, S., & Lee, R. W. (2022) · Cancers · doi:10.3390/cancers14061524 · Cited by 384
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography
Meza, R., Jeon, J., Toumazis, I., ten Haaf, K., Cao, P., Bastani, M., Han, S. S., Blom, E. F., Jonas, D. E., Feuer, E. J., et al. (2021) · JAMA · doi:10.1001/jama.2021.1077 · Cited by 331
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Wolf, A. M. D., Oeffinger, K. C., Shih, Y. T., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R., Guerra, C. E., Perkins, R. B., et al. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21811 · Cited by 326
How to improve access to medical imaging in low- and middle-income countries
Frija, G., Blažić, I., Frush, D. P., Hierath, M., Kawooya, M., Donoso-Bach, L., & Brkljačić, B. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101034 · Cited by 310
Lung cancer in patients who have never smoked — an emerging disease
LoPiccolo, J., Gusev, A., Christiani, D. C., & Janne, P. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00844-0 · Cited by 320
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Banfill, K., Giuliani, M., Aznar, M. C., Franks, K., McWilliam, A., Schmitt, M., Sun, F., Vozenin, M., & Finn, C. F. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.11.002 · Cited by 277
Risk-Based lung cancer screening: A systematic review
Toumazis, I., Bastani, M., Han, S. S., & Plevritis, S. K. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.07.007 · Cited by 268
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
Mithoowani, H., & Febbraro, M. (2022) · Current Oncology · doi:10.3390/curroncol29030150 · Cited by 281
Mazzone, P. J., Silvestri, G. A., Souter, L., Caverly, T. J., Kanne, J. P., Katki, H. A., Wiener, R. S., & Detterbeck, F. C. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.063 · Cited by 268
Cancer evolution: Darwin and beyond
Vendramin, R., Litchfield, K., & Swanton, C. (2021) · The EMBO Journal · doi:10.15252/embj.2021108389 · Cited by 269
The evolution of non-small cell lung cancer metastases in TRACERx
Bakir, M. A., Huebner, A., Martínez‐Ruiz, C., Grigoriadis, K., Watkins, T. B. K., Pich, O., Moore, D. A., Veeriah, S., Ward, S., Laycock, J., et al. (2023) · Nature · doi:10.1038/s41586-023-05729-x · Cited by 263
Rivera, M. P., Katki, H. A., Tanner, N. T., Triplette, M., Sakoda, L. C., Wiener, R. S., Cardarelli, R., Carter‐Harris, L., Crothers, K. A., Fathi, J. T., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3053st · Cited by 241
Field, J. K., Vulkan, D., Davies, M. P. A., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100179 · Cited by 230
Wang, Q., Gumus, Z. H., Colarossi, C., Memeo, L., Wang, X., Kong, C. Y., & Boffetta, P. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.10.002 · Cited by 239
Oliver, A. L. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2021.12.001 · Cited by 217
A mathematical model of ctDNA shedding predicts tumor detection size
Avanzini, S., Kurtz, D. M., Chabon, J. J., Moding, E. J., Hori, S. S., Gambhir, S. S., Alizadeh, A. A., Diehn, M., & Reiter, J. G. (2020) · Science Advances · doi:10.1126/sciadv.abc4308 · Cited by 217
Li, N., Tan, F., Chen, W., Dai, M., Wang, F., Shen, S., Tang, W., Li, J., Yu, Y., Cao, W., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00560-9 · Cited by 208
Deep Learning Reconstruction Shows Better Lung Nodule Detection for Ultra–Low-Dose Chest CT
Jiang, B., Li, N., Shi, X., Zhang, S., Li, J., de Bock, G. H., Vliegenthart, R., & Xie, X. (2022) · Radiology · doi:10.1148/radiol.210551 · Cited by 207
Self-citationAdvances in molecular pathology and therapy of non-small cell lung cancer
Huang, Q., Li, Y., Huang, Y., Wu, J., Bao, W., Xue, C., Li, X., Dong, S., Dong, Z., & Hu, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02243-6 · Cited by 197
Patient Adherence to Screening for Lung Cancer in the US
Lopez-Olivo, M. A., Maki, K. G., Choi, N. J., Hoffman, R. M., Shih, Y. T., Lowenstein, L. M., Hicklen, R., & Volk, R. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.25102 · Cited by 187
Berg, C. D., Schiller, J. H., Boffetta, P., Cai, J., Connolly, C., Kerpel-Fronius, A., Kitts, A. B., Lam, D. C.-L., Mohan, A., Myers, R. L., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.05.024 · Cited by 209
Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT
Venkadesh, K. V., Setio, A. A. A., Schreuder, A., Scholten, E. T., Chung, K., Wille, M. M. W., Saghir, Z., van Ginneken, B., Prokop, M., & Jacobs, C. (2021) · Radiology · doi:10.1148/radiol.2021204433 · Cited by 183
Self-citationLow‐dose computed tomography lung cancer screening: Clinical evidence and implementation research
Lancaster, H. L., Heuvelmans, M. A., & Oudkerk, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13480 · Cited by 185
Self-citationChang, G., Chiu, C., Yu, C., Chang, Y., Chang, Y.-H., Hsu, K.-H., Wu, Y., Chen, C.-Y., Hsu, H., Wu, M., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00338-7 · Cited by 188
ACR Lung-RADS v2022: Assessment Categories and Management Recommendations
Christensen, J. D., Prosper, A. E., Wu, C. C., Chung, J. H., Lee, E., Elicker, B. M., Hunsaker, A. R., Petranović, M., Sandler, K. L., Stiles, B. M., et al. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.09.009 · Cited by 184
Tammemägi, M. C., Ruparel, M., Tremblay, A., Myers, R., Mayo, J., Yee, J., Atkar-Khattra, S., Yuan, R., Cressman, S., English, J., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00590-8 · Cited by 173
Women, power, and cancer: a Lancet Commission
Ginsburg, O., Vanderpuye, V. D. N. K., Beddoe, A. M., Bhoo‐Pathy, N., Bray, F., Caduff, C., Florez, N., Fadhil, I., Hammad, N., Heidari, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01701-4 · Cited by 176
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality
Bonney, A., Malouf, R. S., Marchal, C., Manners, D., Fong, K. M., Marshall, H., Irving, L. B., & Manser, R. L. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013829.pub2 · Cited by 163
Lung Cancer Screening with Low-Dose CT: a Meta-Analysis
Hoffman, R. M., Atallah, R. P., Struble, R. D., & Badgett, R. G. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05951-7 · Cited by 156
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
Casagrande, G. M. S., Silva, M. D. O., Reis, R. M., & Leal, L. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032505 · Cited by 165
Zer, A., Ahn, M., Barlési, F., Bubendorf, L., Ruysscher, D. D., Garrido, P., Gautschi, O. P., Hendriks, L. E. L., Janne, P. A., Kerr, K. M., et al. (2025) · Annals of Oncology · doi:10.1016/j.annonc.2025.08.003 · Cited by 165
Artificial Intelligence in Lung Cancer Screening: The Future Is Now
Cellina, M. I., Cacioppa, L. M., Cè, M., Chiarpenello, V., Costa, M. A. D. S., Vincenzo, Z., Pais, D., Bausano, M. V., Rossini, N., Bruno, A., et al. (2023) · Cancers · doi:10.3390/cancers15174344 · Cited by 166
Estimated Lifetime Gained With Cancer Screening Tests
Bretthauer, M., Wieszczy, P., Løberg, M., Kaminski, M. F., Werner, T. F., Helsingen, L. M., Mori, Y., Holme, Ø., Adami, H., & Kalager, M. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.3798 · Cited by 149
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022
Wood, D. E., Kazerooni, E. A., Aberle, D. R., Berman, A. T., Brown, L. M., Eapen, G. A., Ettinger, D. S., Ferguson, J. S., Hou, L., Kadaria, D., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0036 · Cited by 145
Gao, W., Wen, C. P., Wu, A., & Welch, H. G. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.7769 · Cited by 146
Lung Cancer Screening in Asia: An Expert Consensus Report
Lam, D. C.-L., Liam, C. K., Andarini, S., Park, S., Tan, D. S. W., Singh, N., Jang, S. H., Vardhanabhuti, V., Ramos, A. B., Nakayama, T., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.06.014 · Cited by 158
Lung Cancer Screening in the US, 2022
Bandi, P., Star, J., Ashad‐Bishop, K. C., Kratzer, T. B., Smith, R. A., & Jemal, A. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.1655 · Cited by 145
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Tavernari, D., Battistello, E., Dheilly, E., Petruzzella, A. S., Mina, M., Sordet‐Dessimoz, J., Peters, S., Krueger, T., Gfeller, D., Riggi, N., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1274 · Cited by 138
Application of Artificial Intelligence in Lung Cancer
Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M. (2022) · Cancers · doi:10.3390/cancers14061370 · Cited by 138
Dejima, H., Hu, X. Y., Chen, R., Zhang, J., Fujimoto, J., Parra, E. R., Haymaker, C., Hubert, S. M., Duose, D. Y., Solis, L. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22890-x · Cited by 144
Marquette, C., Boutros, J., Benzaquen, J., Ferreira, M., Pastré, J., Pison, C. M., Padovani, B., Bettayeb, F., Fallet, V., Guibert, N. M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30081-3 · Cited by 139
Sullivan, F., Mair, F. S., Anderson, W., Armory, P., Briggs, A. H., Chew, C., Dorward, A., Haughney, J., Hogarth, F., Kendrick, D., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00670-2020 · Cited by 139
Sosa, E., D’Souza-Rushton, G. C., Akhtar, A., Sur, M., Love, K., Duffels, J., Raz, D. J., Kim, J. Y., Sun, V. C.-Y., & Erhunmwunsee, L. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21671 · Cited by 137
Structural and functional radiomics for lung cancer
Wu, G., Jochems, A., Refaee, T., Ibrahim, A., Yan, C., Sanduleanu, S., Woodruff, H. C., & Lambin, P. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05242-1 · Cited by 141
Current and Future Applications of Virtual, Augmented, and Mixed Reality in Cardiothoracic Surgery
Sadeghi, A. H., el Mathari, S., Abjigitova, D., Maat, A. P. W. M., Taverne, Y. J. H. J., Bogers, A. J. J. C., & Mahtab, E. A. F. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.11.030 · Cited by 133
Accuracy and Reproducibility of Low-Dose Submillisievert Chest CT for the Diagnosis of COVID-19
Dangis, A., Gieraerts, C., Bruecker, Y. D., Janssen, L., Valgaeren, H., Obbels, D., Gillis, M., Ranst, M. A. V., Frans, J., Demeyere, A., et al. (2020) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.2020200196 · Cited by 131
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer
Mederos, N., Friedlaender, A., Peters, S., & Addeo, A. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000796 · Cited by 135
European cancer mortality predictions for the year 2023 with focus on lung cancer
Malvezzi, M., Santucci, C., Boffetta, P., Collatuzzo, G., Levi, F., Vecchia, C. L., & Negri, E. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.01.010 · Cited by 129
Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer
Haren, R. M. V., Delman, A. M., Turner, K. M., Waits, B., Hemingway, M., Shah, S. A., & Starnes, S. L. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.12.002 · Cited by 137
Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma
Nie, M., Yao, K., Zhu, X., Chen, N., Xiao, N., Wang, Y., Peng, B., Yao, L., Li, P., Zhang, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26685-y · Cited by 130
Potter, A. L., Rosenstein, A. L., Kiang, M. V., Shah, S. A., Gaissert, H. A., Chang, D. C., Fintelmann, F. J., & Yang, C. J. (2022) · BMJ · doi:10.1136/bmj-2021-069008 · Cited by 130
Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging
Silvestri, G. A., Goldman, L., Tanner, N. T., Burleson, J., Gould, M. K., Kazerooni, E. A., Mazzone, P. J., Rivera, M. P., Doria-Rose, V. P., Rosenthal, L. S., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.02.003 · Cited by 130
Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules
Lentz, R. J., Frederick-Dyer, K. C., Planz, V. B., Koyama, T., Aboudara, M. C., Avasarala, S. K., Casey, J. D., Cheng, G. Z., D’Haese, P.-F., Duke, J. D., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2414059 · Cited by 130
Yoo, H., Kim, K. H., Singh, R., Digumarthy, S. R., & Kalra, M. K. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.17135 · Cited by 123
Artificial intelligence in lung cancer: current applications and perspectives
Chassagnon, G., de Margerie‐Mellon, C., Vakalopoulou, M., Marini, R., Hoang-Thi, T.-N., Revel, M., & Soyer, P. A. (2022) · Japanese Journal of Radiology · doi:10.1007/s11604-022-01359-x · Cited by 133
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Chen, X., Zhao, D., Hubbell, E. A., Kurtzman, K. N., Oxnard, G. R., Venn, O., Melton, C. A., Clarke, C. A., Shaknovich, R., Ma, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0417 · Cited by 122
Wang, P., Huang, Q., Meng, S., Mu, T., Liu, Z., He, M., Li, Q., Zhao, S., Wang, S., & Qiu, M. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101384 · Cited by 123
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A. G. N., Celli, B. R., Criner, G. J., Halpin, D. M. G., Anzueto, A., Barnes, P. J., Bourbeau, J., Han, M. K., Martínez, F. J., de, M. M., et al. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.02.009 · Cited by 135
Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation
Sands, J. M., Tammemägi, M. C., Couraud, S., Baldwin, D., Kitts, A. B., Yankelevitz, D. F., Lewis, J. V., Grannis, F., Kauczor, H., von Stackelberg, O., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.10.127 · Cited by 117
Folch, E. E., Bowling, M., Pritchett, M. A., Murgu, S. D., Nead, M. A., Flandes, J., Krimsky, W. S., Mahajan, A. K., LeMense, G. P., Murillo, B. A., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.12.008 · Cited by 116
Pastorino, U., Boeri, M., Sestini, S., Sabia, F., Milanese, G., Silva, M., Suatoni, P., Verri, C., Cantarutti, A., Sverzellati, N., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.01.008 · Cited by 117
Association of Stage Shift and Population Mortality Among Patients With Non–Small Cell Lung Cancer
Flores, R. M., Patel, P. B., Alpert, N., Pyenson, B. S., & Taioli, E. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.37508 · Cited by 117
Advances in lung cancer screening and early detection
Li, C., Wang, H., Jiang, Y., Fu, W., Liu, X., Zhong, R., Cheng, B., Zhu, F., Xiang, Y., He, J., et al. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0690 · Cited by 122
Podolanczuk, A. J., Hunninghake, G. M., Wilson, K. C., Khor, Y. H., Kheir, F. M., Pang, B., Adegunsoye, A., Cararie, G., Corte, T. J., FLANAGAN, J., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202505-1054st · Cited by 120
Lu, M. T., Raghu, V. K., Mayrhofer, T., Aerts, H. J. W. L., & Hoffmann, U. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1868 · Cited by 123
Disparities in Cancer Prevention in the COVID-19 Era
Carethers, J. M., Sengupta, R., Blakey, R., Ribas, A., & DʼSouza, G. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0447 · Cited by 111
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Lawler, M., Davies, L., Oberst, S., Oliver, K. R., Eggermont, A. M. M., Schmutz, A., Vecchia, C. L., Allemani, C., Lievens, Y. N., Naredi, P. L. J., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00540-x · Cited by 116
The translational challenges of precision oncology
Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 116
Yin, X., Liao, H., Hong, Y., Lin, N., Li, S., Xiang, Y., & Ma, X. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.002 · Cited by 113
Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches
Warkentin, M. T., Al‐Sawaihey, H., Lam, S. C., Liu, G., Diergaarde, B. B., Yuan, J., Wilson, D. O., Atkar-Khattra, S., Grant, B., Brhane, Y., et al. (2024) · Thorax · doi:10.1136/thorax-2023-220226 · Cited by 114
Kuang, Z., Wang, J., Liu, K., Wu, J., Ge, Y., Zhu, G., Cao, L., Ma, X., & Li, J. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102804 · Cited by 107
Yang, H., Sun, B., Fan, L., Ma, W., Xu, K., Hall, S. R. R., Wang, Z., Schmid, R. A., Peng, R., Marti, T. M., et al. (2022) · Theranostics · doi:10.7150/thno.69590 · Cited by 107
Wu, D., Deng, S., Li, L., Liu, T., Zhang, T., Li, J., Yu, Y., & Xu, Y. X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04004-z · Cited by 104
Conquering lung cancer: current status and prospects for the future
Pirker, R. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2020.02.005 · Cited by 101
Metadata
- Authors
- de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., van ’t Westeinde, S., Prokop, M., Mali, W. P., Mohamed Hoesein, F. A. A., van Ooijen, P. M. A., Aerts, J. G. J. V., den Bakker, M. A., Thunnissen, E., Verschakelen, J., Vliegenthart, R., Walter, J. E., ten Haaf, K., Groen, H. J. M., & Oudkerk, M.
- Affiliations
- From the Departments of Public Health (H.J.K., C.M.A., U.Y.-K., K.H.) and Pulmonology (J.G.J.V.A.), Erasmus MC–University Medical Center Rotterdam, and the Departments of Pulmonology (S.W.) and Pathology (M.A.B.), Maasstad Hospital, Rotterdam, the Departments of Radiology (P.A.J., W.P.M., F.A.A.M.H.) and Pulmonology (J.-W.J.L.), University Medical Center Utrecht, Utrecht, the Departments of Radiology (E.T.S.) and Pulmonology (C.W.), Spaarne Gasthuis, Haarlem, the Department of Radiation Oncology,...
- Erasmus MC (NL)
- Leiden University Medical Center (NL)
- University Medical Center Groningen (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-02-06
- Volume
- 382
- Issue
- 6
- Pages
- 503-513
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3003415550
- Cited by
- 3,624
- References
- 76
- Citations by year
- 2026: 538 · 2025: 626 · 2024: 568 · 2023: 588 · 2022: 532 · 2021: 492 · 2020: 275
- FWCI
- 266.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Lirias (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- LOGO Leuven
- The Netherlands Organization of Health Research and Development
- Dutch Cancer Society
- Health Insurance Innovation Foundation
- Siemens Germany
- Roche Diagnostics
- G.Ph. Verhagen Stichting
- Rotterdam Oncologic Study (ROTS) group
- Erasmus Trust Fund
- Stichting Tegen Kanker
- Vlaamse Liga Tegen Kanker
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- lung cancer screening, low-dose CT, lung cancer mortality, smoking, men, women, screening adherence, lung cancer incidence, NELSON trial, cancer mortality reduction, follow-up procedures, cancer registry linkage, Netherlands, vulnerable populations, cost-effectiveness of screening
- MeSH terms
- Medical Overuse, Aged, Belgium, False Positive Reactions, Female, Humans, Lung Neoplasms, Male, Middle Aged, Netherlands, Registries, Sex Factors, Smoking, Incidence, Cone-Beam Computed Tomography, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
